Wang, H., Shi, L., & Wang, Z. (2021). A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Wang, Hao, Lei Shi, y Zhimin Wang. A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Wang, Hao, et al. A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma. Frontiers Media S.A, 2021.
Precaución: Estas citas no son 100% exactas.